相关实验视频

Updated: Jun 23, 2026

Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide

Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide

Published on: January 15, 2017

基于人工智能的软件用于大血管阻塞中风的实施,可以改善综合性中风中心的门到穿孔时间

Murtaza Akhter^1,2, Christine Ibrahim³, Kara Nolan⁴

¹Penn State Hershey Medical Center, Hershey, PA, USA. murtazaakhter@gmail.com.

Internal and emergency medicine

|November 19, 2025

概括

人工智能 (AI) 显著改善了急性缺血性中风 (AIS) 护理,通过减少内血管血栓切除术 (EVT) 的门到关节时间. 这种AI实施增加了AIS患者及时接受EVT的数量,优化了中风工作流程.

科学领域:

神经学神经学
医疗技术医疗技术医学技术
医疗信息学医疗信息学

背景情况:

内血管血栓切除术 (EVT) 是针对大血管封闭 (LVO) 和急性缺血性中风 (AIS) 的标准治疗方法.
达到90分钟以下的门到设备的时间对于最佳的EVT结果至关重要.
以前的研究表明,人工智能 (AI) 可以缩短中风护理中的治疗时间.

研究的目的:

评估AI软件 (Viz LVO) 对EVT工作流程和患者结果在多样化的城市患者群体中的影响.
评估AI实施对接受EVT的AIS患者的门到设备和门到关节时间的影响.

主要方法:

追溯队列研究分析了2018年7月至2022年7月期间接受EVT的222名患者的数据.
在2020年7月实施Viz LVO AI软件之前 (n=84) 和之后 (n=138) 的工作流和结果的比较.
主要结局:在90分钟内治疗EVT患者的比例;次要结局:门到关节 (DTG) 时间.

主要成果:

在90分钟内接受EVT的患者比例显著增加,从26.5%增加到68.1% (p < 0.001).
门到骨 (DTG) 的中位时间从109分钟显著减少到75分钟 (p < 0.001).
在TICI得分,逗留时间或死亡率/临终关怀率方面没有发现显著差异.

结论:

实施一个人工智能驱动的平台显著提高了及时EVT的速度,并减少了AIS患者的DTG时间.
人工智能系统可以优化城市中心的中风护理工作流程,为不同的人口提供服务.
人工智能在提高对时间敏感性中风干预的效率方面表现有前途,而不会影响临床结果.

关键词:

人工智能的人工智能是人工智能.大型船只的封闭.一次性中风,中风.进行血栓切除术 (thrombectomy).

更多相关视频

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Optimization of the Longa Middle Cerebral Artery Occlusion Method for Complete Reperfusion

Optimization of the Longa Middle Cerebral Artery Occlusion Method for Complete Reperfusion

Published on: November 22, 2024

相关概念视频

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

Aortic Regurgitation III: Medical Management

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...